Table 3

Estimated total costs of treating five identified diseases and potential savings/benefits associated with increased breastfeeding rates in the UK (£, million, 2009–2010 prices)

GastrointestinalLower respiratory tract infectionAcute otitis mediaNecrotising enterocolitis (NEC)Maternal breast cancer (BC)
Hp ValuesTotalHp ValuesTotalp ValuesTotal- acute diseasesTreatment costsTreatment costsValue health gains*Total
Current treatment costs13.421.3314.7550.256.6556.903.8575.513.54959.50NA959.50
Savings with
 Policy A11.200.141.342.160.302.460.284.08
Policy A23.250.383.635.850.806.650.7611.04
 Policy A34.960.585.548.931.2210.251.1616.95
 Policy B10.560.070.631.000.141.140.131.9
 Policy C11.680.231.914.160.594.750.627.28
 Policy D12.30
Policy D26.12
 Policy D39.95
 Policy E115.347.4222.76
Policy E221.1710.2531.42
 Policy E327.8013.4641.26
Total savings from mid-level policy scenario (Policy A2)—acute diseases11.04
Total savings from mid-level policy scenario (Policy D2)—NEC6.12
Total savings from mid-level policy scenario (Policy E2)—BC (without value of health gains)21.17
Total benefits from mid-level policy scenario (Policy E2)—BC (with value of health gains)31.42
  • The italics face is used to differentiate table 3 from table 4. One provides ‘total’, the other provides ‘average’ figures. The bold face highlight policies that are recommended as realistic targets in the discussion section.

  • *Monetary value of health (QALY) gains @ £20 000/QALY;

  • NA, Not applicable.

  • H, hospitalisation costs; P, primary care costs.